Exploring how NRF2 affects metabolism in lung cancer
Investigation of NRF2-Dependent Metabolic Liabilities
This study is looking at how a protein called NRF2 affects the way non-small cell lung cancer grows and survives, using special mice to see how changes in this protein and its partner KEAP1 impact cancer, with the goal of finding better treatments by understanding how tumors produce an important antioxidant called glutathione.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10928697 on NIH RePORTER |
What this research studies
This research investigates the role of NRF2, a protein that influences metabolic changes in non-small cell lung cancer (NSCLC). By studying genetically modified mouse models, the team aims to understand how mutations in NRF2 and its regulator KEAP1 contribute to cancer growth and survival. The research focuses on the production of glutathione, an important antioxidant, and how its synthesis is altered in tumors. Through advanced metabolomics techniques, the study seeks to uncover the mechanisms behind these metabolic changes and their implications for cancer therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with non-small cell lung cancer, particularly those with mutations in NRF2 or KEAP1.
Not a fit: Patients with other types of lung cancer or those without NRF2 or KEAP1 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies targeting metabolic pathways in lung cancer.
How similar studies have performed: Previous research has shown promising results in targeting metabolic pathways in cancer, suggesting that this approach may yield significant insights.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Denicola, Gina Marie — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Denicola, Gina Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.